|
3. What Is SOLIFEN 5mg and What Is It Used
For? |
What Is SOLIFEN 5mg?
Solifen 5mg contains
Solifenacin Succinate, a selective anticholinergic medicine that targets the M3
muscarinic receptors specifically found in the bladder muscle (detrusor
muscle). By selectively blocking these receptors, Solifenacin reduces the involuntary
bladder contractions that cause the sudden, uncontrollable urge to urinate that
characterises Overactive Bladder syndrome.
Compared to older, less
selective anticholinergics like Oxybutynin, Solifenacin's M3 selectivity means
it is more targeted to the bladder, producing effective urinary control with
generally fewer non-bladder side effects such as dry mouth and cognitive
effects, making it particularly suitable for older patients.
What Is It Used For?
Solifen 5mg is prescribed for
people with Overactive Bladder (OAB), a condition that causes the sudden,
urgent need to urinate that can be hard or impossible to control, leading to
involuntary urine leakage (urge incontinence), very frequent urination during
the day, and multiple waking episodes at night (nocturia).
OAB is more common with
increasing age, in women (particularly after menopause), and in men with
prostate conditions. It can significantly affect daily activities, social
confidence, sleep quality, and emotional wellbeing. Solifen helps reduce these
symptoms, giving patients greater bladder control, fewer daily bathroom visits,
and better sleep.
In Kenya, it is prescribed by
urologists and general practitioners for both men and women with established
OAB.
|
4. How to Take This Medicine |
Usual Dose
5mg once daily, swallowed
whole with water, with or without food.
Dose Adjustment
The dose may be increased to
10mg once daily if 5mg is well tolerated but insufficiently effective, only on
medical advice.
Consistency
Take at the same time every
day for consistent blood levels and bladder control.
Swallow Whole
Do not crush or chew the
tablet.
Missed Dose
Take as soon as remembered on
the same day. If a full day has passed, skip and continue from the next. Never
double dose.
Duration
Reassess benefit and
tolerability after 4–8 weeks. Long-term use under medical review is appropriate
if benefit continues.
|
5. Side Effects |
Common Side Effects
· Dry
mouth (most common, worse at the 10mg dose)
· Constipation
· Blurred
vision
· Dry
eyes
· Urinary
retention (difficulty fully emptying bladder, especially in men with prostatic
obstruction)
Uncommon Side Effects
· Nausea
· Headache
· Fatigue
· Abdominal
pain
Serious Side Effects, Seek Immediate Medical Attention
· Acute
urinary retention, inability to urinate at all (seek emergency care)
· Angle-closure
glaucoma precipitation
· Tachycardia
and palpitations
· CNS
effects in elderly: confusion, hallucinations (less than with Oxybutynin but
still possible)
|
6. Contraindications |
|
⚠ The following
patients should NOT use this medication: • Urinary retention • Gastric retention or severe decreased GI motility • Uncontrolled narrow-angle glaucoma • Myasthenia gravis • Severe renal impairment (eGFR < 30 ml/min)
without dose adjustment • Severe hepatic impairment • Hypersensitivity to solifenacin • Concurrent use with strong CYP3A4 inhibitors at
10mg dose
|
|
7. Safety Warnings and Special Precautions |
· URINARY
RETENTION: Men with BPH (enlarged prostate) are at increased risk of urinary
retention, prostate obstruction must be assessed before prescribing.
· GLAUCOMA:
Do not use in uncontrolled narrow-angle glaucoma, consult an ophthalmologist
before starting.
· ELDERLY:
Monitor for confusion and cognitive effects, anticholinergic burden must be
considered carefully in older patients on multiple medications.
· RENAL
/ HEPATIC IMPAIRMENT: Dose capping at 5mg in moderate renal or hepatic
impairment; avoid in severe impairment.
· HEAT
RISK: Reduced sweating in hot conditions, advise caution in strenuous outdoor
activity or hot environments.
· DRIVING:
Blurred vision and dizziness can occur, do not drive until the effect of the
medicine is known.
|
8. Drug Interactions |
Strong
CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir): Significantly
increase solifenacin levels, cap dose at 5mg; avoid 10mg dose in combination.
Other
anticholinergic drugs: Additive anticholinergic
burden, dry mouth, constipation, urinary retention, confusion.
QT-prolonging
drugs: Solifenacin prolongs QT, avoid combination with
amiodarone, haloperidol, or other QT-prolonging agents.
CYP3A4
inducers (rifampicin, phenytoin): May reduce solifenacin
efficacy.
|
9. Storage Instructions |
· Store
below 25°C in a cool, dry place.
· Protect
from moisture and light.
· Keep
in original packaging.
· Keep
out of reach of children.
|
10. Prescription Status in Kenya |
Solifen 5mg is a
prescription-only medicine (POM) in Kenya. It must be prescribed by a
urologist, gynaecologist, or physician. Available at Pharmily with a valid
prescription.
|
11. Patient Guidance |
|
💊 Key Points
for Patients: ✔ Take your Solifen 5mg tablet once
daily at the same time, with or without food. ✔ Dry mouth is very common, sip water
frequently, chew sugar-free gum, or use a saliva spray to manage this. ✔ Increase fluid and fibre intake to
counteract the constipation that Solifen can cause. ✔ If you develop any difficulty
urinating, stop the medicine and seek medical care, this could indicate
urinary retention. ✔ Be cautious in hot weather or
strenuous activity, this medicine can reduce your ability to sweat. ✔ Do not drive or operate machinery
until you know how Solifen affects your vision and concentration.
|
|
12. Pharmacist / Prescriber Notes |
Solifen 5mg (Solifenacin) is a
preferred antimuscarinic for OAB due to its M3 selectivity and relatively lower
incidence of CNS anticholinergic effects compared to Oxybutynin. The CYP3A4
inhibitor interaction is clinically significant, ketoconazole or itraconazole
concurrent use caps the dose at 5mg maximum and should be flagged at
dispensing. Rifampicin interaction (TB treatment) reduces efficacy, relevant in
Kenya.
Screen for concurrent
anticholinergic medications (antihistamines, TCA antidepressants, bladder
medications) and calculate cumulative anticholinergic burden, especially in
elderly patients. The QT prolongation interaction requires screening for
concurrent QT-prolonging drugs.
BPH assessment is essential in
male patients, post-void residual volume > 150ml or significant obstructive
symptoms are relative contraindications. The 10-tablet pack provides only a
10-day supply, advise the prescriber or patient to plan for a 30-day pack for
continuous therapy.
|
13. Frequently Asked Questions (FAQs) |
How is Solifen different from Oxifast (Oxybutynin)?
A: Both treat overactive
bladder, but Solifen (Solifenacin) is more selective for the bladder's M3
muscarinic receptors. This means it tends to cause fewer non-bladder side
effects like dry mouth and cognitive effects, making it generally better
tolerated, especially in older adults.
How quickly does Solifen work?
A: Many people notice some
improvement in urgency and frequency within the first 1–2 weeks, with fuller
benefit developing over 4–8 weeks. Your doctor will reassess the dose after
this period.
Can I take Solifen if I have an enlarged prostate?
A: Men with an enlarged
prostate must be assessed by a urologist before taking Solifen; the
bladder-relaxing effect can worsen urinary obstruction and in some cases cause
complete urinary retention.
Why is my mouth so dry on Solifen?
A: Solifen blocks muscarinic
receptors in both the bladder and salivary glands, reducing saliva production.
Sip water regularly throughout the day, chew sugar-free gum, or ask your
pharmacist about a saliva spray to manage this.
There are no product reviews yet.